Skip to main content
< Back
About
About the conference
Organisers & Partners
Registration
App
Podcast
Early Career Researchers
Call for abstracts
Guidelines
Latest updates
Press room
Venue
Programme
Full programme
Programme outline
Tracks
Speakers
All speakers
Keynote speakers
Side events
Subscribe
Programme
Keywords
Africa
Alcohol
Asia
Basic research
Behavioural addictions
Cannabis
Capacity-building
Civil society
Clinical research/practice
Comorbidity
COVID-19
Criminal justice/prisons
Criminology
Drug user's perspectives
E-health/digitalisation
ECR (Early Career Researchers)
Europe
Gender perspectives
Harm reduction
Health inequalities
Hepatitis
HIV
Infectious diseases
Markets
Mental health and wellbeing
Monitoring and evaluation
Neuroscience
New psychoactive substances
Nicotine/tobacco
North America
Oceania
Opiates
Overdose
Policy
Prescription drugs
Prevention
Psychostimulants
Public health
Qualitative methods
Quantitative methods
Recreational setting
Risky behaviours
South America
Toxicology and forensic analysis
Treatment
Underrepresented groups
Workforce
Youth/children
- Any -
WED
23 OCT
THU
24 OCT
FRI
25 OCT
All
Plenary session
Big debate
Major session
Workshop
Oral presentation session
Short communication session
e-short communication session
e-poster session
Video contest
PDF version
Wed 23 Oct
11:50
Mechanisms and outcomes in substance use prevention among youth
11:50
to
13:20
Room 5A
Oral presentation session
14:20
Legal shifts and their Impact on drug use and sentencing
14:20
to
15:50
Auditorium IV
Oral presentation session
Gender and substance use
14:20
to
15:50
Auditorium VIII
Oral presentation session
Challenge of measuring use and impact of cannabinoids
14:20
to
15:50
Room 1.07
Oral presentation session
16:00
Measuring drug market phenomenon
16:00
to
17:30
Auditorium VI
Oral presentation session
Substance use and psychosis
16:00
to
17:30
Auditorium VII
Oral presentation session
17:50
Understanding interrelationships: mental health and substance use
17:50
to
19:20
Auditorium VII
Oral presentation session
Thu 24 Oct
11:50
Evidence informed drug and alcohol policy
11:50
to
13:20
Auditorium VI
Oral presentation session
Contemporary issues
11:50
to
13:20
Room 1.08
Oral presentation session
14:20
Novel neurobiology - cannabis, cognition and craving
14:20
to
15:50
Auditorium III
Oral presentation session
Conceptual frameworks for studying drug policy
14:20
to
15:50
Auditorium VI
Oral presentation session
Young people, mental health and substance use
14:20
to
15:50
Auditorium VII
Oral presentation session
Public health and safety impacts of cannabis legalization in Canada: five years in review
14:20
to
15:50
Auditorium IV
Oral presentation session
Pregnancy, drug use and care
14:20
to
15:50
Room 5B
Oral presentation session
16:00
NPS: Pharmacological Characterization and Substance Analysis
16:00
to
17:30
Auditorium III
Oral presentation session
Cannabis legalisation — models and impacts
16:00
to
17:30
Auditorium VI
Oral presentation session
Protective and risk factors in drug prevention
16:00
to
17:30
Room 5A
Oral presentation session
Drug trends: experiences from Brazil, the Netherlands, Portugal, and Spain
16:00
to
17:30
Room 1.08
Oral presentation session
17:50
Substance use and mental health in treatment settings
17:50
to
19:20
Auditorium VII
Oral presentation session
Misuse of medicines
17:50
to
19:20
Auditorium VIII
Oral presentation session
New Research on Alcohol and Tobacco Policy
17:50
to
19:20
Room 5A
Oral presentation session
Fri 25 Oct
11:50
Online monitoring
11:50
to
13:20
Room 5B
Oral presentation session
14:20
Young people and drugs
14:20
to
15:50
Auditorium III
Oral presentation session
Regulating cannabis supply policies in Europe: navigating the long road to change
14:20
to
15:50
Auditorium VIII
Oral presentation session
Impact of drug policy on drug production & markets
14:20
to
15:50
Room 5B
Oral presentation session
MENU
Back
www.lisbonaddictions.eu
My profile
Notifications
My favourites
Scan contacts
My contacts
Settings